Alcon Growth
Featured in:
Articles
-
Oct 15, 2024 |
insights.citeline.com | Alcon Growth |Sten Stovall
Novartis CEO Sees Recovery Ahead, Fueled By Pipeline And Alcon Growth18 Jul 2017 • By Sten StovallNovartis' half-year results show eye business Alcon and heart drug Entresto - which have been the two main sources of concern - are finally turning around, and its pipeline is firing on all cylinders towards a post-Gleevec recovery. Novartis' CEO Sees Recovery Ahead, powered by pipeline assets, Alcon growth • Source: Shutterstock
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →